BioCentury
ARTICLE | Company News

Beyond Genomics, AstraZeneca deal

February 9, 2004 8:00 AM UTC

Beyond Genomics will use its systems biology platform and BioSystematics informatics tools to identify biomarkers of drug-induced toxicity for AZN. Beyond Genomics' technology analyzes and integrates ...